• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Victoza (liraglutide [rDNA origin]) injection

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

December 2012

Summary View

 

ADVERSE REACTIONS

  • Allergic reactions: rash and pruritus

 

December 2010

Summary View

 

Adverse Reactions

Clinical Trials Experience
  • Infomration added to section based on trial reports, Liraglutide Effect and Action in Diabetes (LEAD-6): Effect on glycemic control of liraglutide or exenatide added to metformin, sulphonylurea or a combination of both in subjects with type 2 diabetes.